Literature DB >> 18164360

Single whole-body exposure to sarin vapor in rats: long-term neuronal and behavioral deficits.

Ettie Grauer1, Shira Chapman, Ishai Rabinovitz, Lily Raveh, Ben-Avi Weissman, Tamar Kadar, Nahum Allon.   

Abstract

Freely moving rats were exposed to sarin vapor (34.2+/-0.8 microg/l) for 10 min. Mortality at 24 h was 35% and toxic sings in the surviving rats ranged from sever (prolonged convulsions) through moderate to almost no overt signs. Some of the surviving rats developed delayed, intermittent convulsions. All rats were evaluated for long-term functional deficits in comparison to air-exposed control rats. Histological analysis revealed typical cell loss at 1 week post inhalation exposure. Neuronal inflammation was demonstrated by a 20-fold increase in prostaglandin (PGE(2)) levels 24 h following exposure that markedly decreased 6 days later. An additional, delayed increase in PGE(2) was detected at 1 month and continued to increase for up to 6 months post exposure. Glial activation following neural damage was demonstrated by an elevated level of peripheral benzodiazepine receptors (PBR) seen in the brain 4 and 6 months after exposure. At the same time muscarinic receptors were unaffected. Six weeks, four and six months post exposure behavioral evaluations were performed. In the open field, sarin-exposed rats showed a significant increase in overall activity with no habituation over days. In a working memory paradigm in the water maze, these same rats showed impaired working and reference memory processes with no recovery. Our data suggest long lasting impairment of brain functions in surviving rats following a single sarin exposure. Animals that seem to fully recover from the exposure, and even animals that initially show no toxicity signs, developed some adverse neural changes with time.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164360     DOI: 10.1016/j.taap.2007.11.006

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  16 in total

Review 1.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 2.  A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation.

Authors:  Christopher N Banks; Pamela J Lein
Journal:  Neurotoxicology       Date:  2012-02-10       Impact factor: 4.294

Review 3.  Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review.

Authors:  Mohamed B Abou-Donia; Briana Siracuse; Natasha Gupta; Ashly Sobel Sokol
Journal:  Crit Rev Toxicol       Date:  2016-10-05       Impact factor: 5.635

4.  Editor's Highlight: Spatiotemporal Progression and Remission of Lesions in the Rat Brain Following Acute Intoxication With Diisopropylfluorophosphate.

Authors:  Sílvia Sisó; Brad A Hobson; Danielle J Harvey; Donald A Bruun; Douglas J Rowland; Joel R Garbow; Pamela J Lein
Journal:  Toxicol Sci       Date:  2017-06-01       Impact factor: 4.849

5.  Soman increases neuronal COX-2 levels: possible link between seizures and protracted neuronal damage.

Authors:  Mariana Angoa-Pérez; Christian W Kreipke; David M Thomas; Kerry E Van Shura; Megan Lyman; John H McDonough; Donald M Kuhn
Journal:  Neurotoxicology       Date:  2010-07-01       Impact factor: 4.294

Review 6.  Persistent behavior deficits, neuroinflammation, and oxidative stress in a rat model of acute organophosphate intoxication.

Authors:  Michelle Guignet; Kiran Dhakal; Brenna M Flannery; Brad A Hobson; Dorota Zolkowska; Ashish Dhir; Donald A Bruun; Shuyang Li; Abdul Wahab; Danielle J Harvey; Jill L Silverman; Michael A Rogawski; Pamela J Lein
Journal:  Neurobiol Dis       Date:  2019-03-21       Impact factor: 5.996

Review 7.  Novel therapeutics for treating organophosphate-induced status epilepticus co-morbidities, based on changes in calcium homeostasis.

Authors:  Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Neurobiol Dis       Date:  2019-03-12       Impact factor: 5.996

Review 8.  The role of glutamate and the immune system in organophosphate-induced CNS damage.

Authors:  Arik Eisenkraft; Avshalom Falk; Arseny Finkelstein
Journal:  Neurotox Res       Date:  2013-03-27       Impact factor: 3.911

Review 9.  Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents.

Authors:  Isaac N Pessah; Michael A Rogawski; Daniel J Tancredi; Heike Wulff; Dorota Zolkowska; Donald A Bruun; Bruce D Hammock; Pamela J Lein
Journal:  Ann N Y Acad Sci       Date:  2016-07-28       Impact factor: 5.691

10.  Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Carol E Green; Robert Swezey; Chun Yang; Felicia Qashu; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2012-10-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.